← Back to Clinical Trials
Recruiting NCT06403839

NCT06403839 Impact of Preoperative Dental Screening in Reducing Infective Endocarditis Risk in Surgical Valve Replacement Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06403839
Status Recruiting
Phase
Sponsor Odense University Hospital
Condition Surgical Valve Replacement
Study Type OBSERVATIONAL
Enrollment 1,000 participants
Start Date 2020-01-01
Primary Completion 2027-03-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
No preoperative dental screening

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 1,000 participants in total. It began in 2020-01-01 with a primary completion date of 2027-03-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

In Odense University Hospital preoperative dental screening (PDS) protocol for patients treated with surgical valve replacement was changed from mandatory to targeted PDS to from march 2024. The investigators will therefore compare the risk of IE before vs after march 2024.

Eligibility Criteria

Inclusion Criteria: * Patients undergoing surgical valve replacement Exclusion Criteria: * None

Contact & Investigator

Central Contact

Lytfi Krasniqi, MD

✉ Lytfi.Krasniqi@rsyd.dk

📞 004524638899

Principal Investigator

Lytfi Krasniqi, MD

PRINCIPAL INVESTIGATOR

Denmark Odense University Hospital

Frequently Asked Questions

Who can join the NCT06403839 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Surgical Valve Replacement. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06403839 currently recruiting?

Yes, NCT06403839 is actively recruiting participants. Contact the research team at Lytfi.Krasniqi@rsyd.dk for enrollment information.

Where is the NCT06403839 trial being conducted?

This trial is being conducted at Odense, Denmark.

Who is sponsoring the NCT06403839 clinical trial?

NCT06403839 is sponsored by Odense University Hospital. The principal investigator is Lytfi Krasniqi, MD at Denmark Odense University Hospital. The trial plans to enroll 1,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology